Our Approach To Intraocular Melanoma in Adults

Find a Doctor Find a Clinical Trial Or Call Us: 646-929-7950

What Sets Us Apart

Eye cancer specialists at NYU Langone’s Perlmutter Cancer Center are leaders in diagnosing and treating intraocular melanoma. This cancer begins in structures within the blood vessel-rich area of the eye known as the uvea.

Our internationally recognized ophthalmic oncologists—doctors who specialize in treating eye cancer—have pioneered many of the vision-sparing diagnostic and treatment approaches currently used for people with intraocular melanoma.

VISIONARY THINKING AND COMPASSIONATE CARE
 

At NYU Langone’s Perlmutter Cancer Center, a National Cancer Institute-designated cancer center, we personalize the care of every patient.More About Perlmutter Cancer Center

CLINICAL TRIALS and Research Studies
 

Our teams of physicians and scientists work together across multiple disciplines to bring our patients the most innovative clinical trials.Find a Clinical Trial

Treatment is aimed at destroying the tumor, preserving vision, and preventing the disease from spreading. Rehabilitation medicine specialists at NYU Langone’s Rusk Rehabilitation can help you adjust to any changes in your vision caused by the cancer or treatment.

Treatment at NYU Langone

Radiation therapy, a vision-sparing alternative to surgery, is the most common treatment for intraocular melanoma. For people with intraocular melanomas that have spread, localized treatments or systemic therapy may be needed.

More Resources

Meet Our Doctors

NYU Langone specialists provide care and support throughout your entire healthcare journey.

Browse Doctors